MX341213B - Uso de nifuratel para tratar infecciones causadas por una especie del genero clostridium. - Google Patents

Uso de nifuratel para tratar infecciones causadas por una especie del genero clostridium.

Info

Publication number
MX341213B
MX341213B MX2013009686A MX2013009686A MX341213B MX 341213 B MX341213 B MX 341213B MX 2013009686 A MX2013009686 A MX 2013009686A MX 2013009686 A MX2013009686 A MX 2013009686A MX 341213 B MX341213 B MX 341213B
Authority
MX
Mexico
Prior art keywords
nifuratel
infections caused
treat infections
clostridium species
treat
Prior art date
Application number
MX2013009686A
Other languages
English (en)
Other versions
MX2013009686A (es
Inventor
Bulgheroni Anna
Mailland Federico
Iob Giuliana
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of MX2013009686A publication Critical patent/MX2013009686A/es
Publication of MX341213B publication Critical patent/MX341213B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención está dirigida al uso de nifuratel, o una sal del mismo fisiológicamente aceptable, para tratar infecciones causadas por una especie de bacterias del género Clostridium. La invención está dirigida además al uso de nifuratel para tratar una infección con Clostridium difficile (GDI) y en particular diarrea asociada con Clostridium difficile (CDAD).
MX2013009686A 2011-02-22 2012-01-19 Uso de nifuratel para tratar infecciones causadas por una especie del genero clostridium. MX341213B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11155283A EP2491929A1 (en) 2011-02-22 2011-02-22 Use of Nifuratel to treat infections caused by Clostridium species
PCT/EP2012/050759 WO2012113594A1 (en) 2011-02-22 2012-01-19 Use of nifuratel to treat infections caused by clostridium species

Publications (2)

Publication Number Publication Date
MX2013009686A MX2013009686A (es) 2013-12-06
MX341213B true MX341213B (es) 2016-08-11

Family

ID=44059064

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009686A MX341213B (es) 2011-02-22 2012-01-19 Uso de nifuratel para tratar infecciones causadas por una especie del genero clostridium.

Country Status (24)

Country Link
EP (2) EP2491929A1 (es)
KR (1) KR20140021525A (es)
CN (1) CN103384523B (es)
AR (1) AR085266A1 (es)
BR (1) BR112013015974A2 (es)
CL (1) CL2013002098A1 (es)
CY (1) CY1116210T1 (es)
DK (1) DK2678015T3 (es)
EA (1) EA025645B1 (es)
ES (1) ES2529210T3 (es)
GE (1) GEP20156264B (es)
HK (1) HK1187553A1 (es)
HR (1) HRP20150141T1 (es)
ME (1) ME02056B (es)
MX (1) MX341213B (es)
PL (1) PL2678015T3 (es)
PT (1) PT2678015E (es)
RS (1) RS53739B1 (es)
SI (1) SI2678015T1 (es)
SM (1) SMT201500039B (es)
TW (1) TWI536989B (es)
UA (1) UA113159C2 (es)
UY (1) UY33915A (es)
WO (1) WO2012113594A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102885793B (zh) * 2012-10-15 2014-08-20 山东罗欣药业股份有限公司 一种硝呋太尔组合物片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000255A1 (en) * 2001-06-25 2003-01-03 Essential Therapeutics, Inc. Novel nitrofuran-containing heterocyclic compounds and uses thereof
EP2243482A1 (en) 2009-04-20 2010-10-27 Polichem SA Use of nifuratel to treat infections caused by atopobium species

Also Published As

Publication number Publication date
TWI536989B (zh) 2016-06-11
DK2678015T3 (en) 2015-01-26
SMT201500039B (it) 2015-03-05
CL2013002098A1 (es) 2014-06-06
EA201370179A1 (ru) 2014-03-31
GEP20156264B (en) 2015-03-25
PL2678015T3 (pl) 2015-04-30
BR112013015974A2 (pt) 2018-06-05
RS53739B1 (en) 2015-06-30
EP2678015A1 (en) 2014-01-01
WO2012113594A1 (en) 2012-08-30
ME02056B (me) 2015-05-20
MX2013009686A (es) 2013-12-06
UA113159C2 (xx) 2016-12-26
AR085266A1 (es) 2013-09-18
CN103384523B (zh) 2015-04-29
ES2529210T3 (es) 2015-02-18
EP2678015B1 (en) 2014-11-26
PT2678015E (pt) 2015-02-10
CY1116210T1 (el) 2017-02-08
HRP20150141T1 (en) 2015-03-13
KR20140021525A (ko) 2014-02-20
EA025645B1 (ru) 2017-01-30
HK1187553A1 (en) 2014-04-11
UY33915A (es) 2012-04-30
EP2491929A1 (en) 2012-08-29
CN103384523A (zh) 2013-11-06
TW201309292A (zh) 2013-03-01
SI2678015T1 (sl) 2015-03-31

Similar Documents

Publication Publication Date Title
WO2012106735A3 (en) Plasma-assisted skin treatment
JO3357B1 (ar) مركبات إيميدازوبيروليدينون
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
MX348348B (es) Extracto de aguacate enriquecido en compuestos bioactivos con actividad antimicrobiana, antibacteriana e inhibidora de la germinacion de esporas bacterianas.
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
MX363004B (es) Formulaciones desinfectantes tópicas y usos de las mismas.
WO2012116010A3 (en) Antibiotic tolerance inhibitors
MX354988B (es) Formulaciones de anticuerpo y metodos.
WO2012129341A3 (en) Disease detection in plants
GB2518813A (en) OMV vaccine against Burkholderia infections
MY179243A (en) Supplemented fish feed
WO2013106689A8 (en) Hcv ns3 protease inhibitors
MX2011006803A (es) Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
PH12014502680A1 (en) Polysaccharide compositions and methods of use
EP2575833A4 (en) THERAPEUTIC AMOUNTS AND USES THEREOF
MX2017009094A (es) Derivado de polimixina y usos del mismo.
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
MX2013004906A (es) Nuevos inhibidores especificos de la proteasa ns3 de hcv.
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
GEP20197052B (en) Hyr1-derived compositions and methods of treatment using same
MX341213B (es) Uso de nifuratel para tratar infecciones causadas por una especie del genero clostridium.
ZA201308256B (en) Uses, methods and biological compositions of the genus paecilomyces for the control, prevention and eradication of phytoparasites in solanaceae cultures
MX2013014999A (es) Peptido mejorador de sabor.

Legal Events

Date Code Title Description
FG Grant or registration